Micaela Domingues

Micaela Domingues

Auto-generated profile, based on publicly available information

Micaela Domingues

Technological Development Center, Division of Biotechnology, Neurobiotechology Research Group, Federal University of Pelotas, Pelotas, RS, Brazil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NHNicholas Hanuscheck
Nicholas Hanuscheck
CTCarine Thalman
Carine Thalman
MDMicaela Domingues
Micaela Domingues
SSSamantha Schmaul
Samantha Schmaul
Muthuraman MuthuramanMuthuraman Muthuraman
Muthuraman Muthuraman
FZFrauke Zipp
Frauke Zipp
Evidence is emerging that immune responses not only play a part in the central nervous system (CNS) in diseases but may also be relevant for healthy conditions. We discovered a major role for the interleukin-4 (IL-4)/IL-4 receptor alpha (IL-4Rα) signaling pathway in synaptic processes, as indicated by transcriptome analysis in IL-4Rα–deficient mice and human neurons with/without IL-4 treatment. Moreover, IL-4Rα is expressed presynaptically, and locally available IL-4 regulates synaptic transmission. We found reduced synaptic vesicle pools, altered postsynaptic currents, and a higher excitatory drive in cortical networks of IL-4Rα–deficient neurons. Acute effects of IL-4 treatment on postsynaptic currents in wild-type neurons were mediated via PKCγ signaling release and led to increased inhibitory activity supporting the findings in IL-4Rα–deficient neurons. In fact, the deficiency of IL-4Rα resulted in increased network activity in vivo, accompanied by altered exploration and anxiety-related learning behavior; general learning and memory was unchanged. In conclusion, neuronal IL-4Rα and its presynaptic prevalence appear relevant for maintaining homeostasis of CNS synaptic function.

12 September 2017 in Asian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
BVBeatriz M. Vieira
Beatriz M. Vieira
STSamuel Thurow
Samuel Thurow
MCMonaliza da Costa
Monaliza da Costa
ACAngela Maria Casaril
Angela Maria Casaril
MDMicaela Domingues
Micaela Domingues
Eder LenardaoEder Lenardao
Eder Lenardao

29 June 2017 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
ACAngela Maria Casaril
Angela Maria Casaril
MDMicaela Domingues
Micaela Domingues
MFMariana Fronza
Mariana Fronza
BVBeatriz Vieira
Beatriz Vieira
KBKarine Begnini
Karine Begnini
LSLucielli Savegnago
Lucielli Savegnago
Organoselenium compounds and indoles have gained attention due to their wide range of pharmacological properties. Depression is a recurrent and disabling psychiatric illness and current evidences support that oxidative stress and neuroinflammation are mechanisms underlying the pathophysiology of this psychiatric condition. Here, we evaluated the effect of 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole (CMI) in lipopolysaccharide (LPS)-induced depressive-like behaviour, neuroinflammation and oxidative stress in male mice. CMI pre-treatment (20 and 50 mg/kg, intragastrically) significantly attenuated LPS (0.83 mg/kg, intraperitoneally)-induced depressive-like behaviour in mice by reducing the immobility time in the tail suspension test (TST) and forced swimming test (FST). CMI pre-treatment ameliorated LPS-induced neuroinflammation by reducing the levels of interleukin (IL)-1β, IL-4 and IL-6 in the hippocampus and prefrontal cortex, as well as markers of oxidative damage. Additionally, we investigated the toxicological effects of CMI (200 mg/kg, i.g.) in the liver, kidney and brain through determination of the activity of aspartate aminotransferase (AST), alanine aminotransferase (ALT), δ-aminolevulinate dehydratase (δ-ALA-D) and creatinine levels. These biomarkers were not modified, indicating the possible absence of neuro-, hepato- and nephrotoxic effects. Our results suggest that CMI could be a therapeutic approach for the treatment of depression and other neuropsychiatric disorders associated with inflammation and oxidative stress.

1 July 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
MDMicaela Domingues
Micaela Domingues
ACAngela Maria Casaril
Angela Maria Casaril
PBPaloma Taborda Birmann
Paloma Taborda Birmann
SBSuely Ribeiro Bampi
Suely Ribeiro Bampi
DLDarling de Andrade Lourenço
Darling de Andrade Lourenço
LSLucielli Savegnago
Lucielli Savegnago

4 January 2019 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
ACAngela Maria Casaril
Angela Maria Casaril
MDMicaela Domingues
Micaela Domingues
SBSuely Ribeiro Bampi
Suely Ribeiro Bampi
DLDarling de Andrade Lourenço
Darling de Andrade Lourenço
NPNathalia Batista Padilha
Nathalia Batista Padilha
LSLucielli Savegnago
Lucielli Savegnago

1 February 2020 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
ACAngela Maria Casaril
Angela Maria Casaril
MDMicaela Domingues
Micaela Domingues
SBSuely Ribeiro Bampi
Suely Ribeiro Bampi
DLDarling de Andrade Lourenço
Darling de Andrade Lourenço
TSThiago Ângelo Smaniotto
Thiago Ângelo Smaniotto
LSLucielli Savegnago
Lucielli Savegnago